Pyrrolidine dithiocarbamate and diethyldithiocarbamate are active against growing and nongrowing persister mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 12, 2007, Pages 4495-4497

  Byrne, Sean T ^a   Gu, Peihua ^a   Zhou, Jiangbing ^a   Denkin, Steven M ^a   Chong, Curtis ^b   Sullivan, David ^a   Liu, Jun O ^b   Zhang, Ying ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLDITHIOCARBAMIC ACID; DISULFIRAM; ISONIAZID; PYRAZINAMIDE; PYRROLIDINE DITHIOCARBAMATE; RIFAMPICIN;

ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; FEMALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTITUBERCULAR AGENTS; DITIOCARB; FEMALE; MICE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; PYRROLIDINES; RIFAMPIN; THIOCARBAMATES;

EID: 36749066063     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00753-07     Document Type: Article

References (8)

1. Centers for Disease Control and Prevention. 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. Morb. Mortal. Wkly. Rep. 55:301-305.
2. Chong, C. R., X. Chen, L. Shi, J. O. Liu, and D. J. Sullivan, Jr. 2006. A clinical drug library screen identifies astemizole as an antimalarial agent. Nat. Chem. Biol. 2:415-416.
3. Chong, C. R., D. Z. Qian, F. Pan, Y. Wei, R. Pili, D. J. Sullivan, Jr., and J. O. Liu. 2006. Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target. J. Med. Chem. 49:2677-2680.
4. Hubner, L., M. Ernst, D. von Laer, S. Schwander, and H. D. Flad. 1991. Enhancement of monocyte antimycobacterial activity by diethyldithiocarbamate (DTC). Int. J. Immunopharmacol. 13:1067-1072.
5. Schreck, R., B. Meier, D. N. Mannel, W. Droge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175:1181-1194.
6. Sebat, J. L., A. J. Paszczynski, M. S. Cortese, and R. L. Crawford. 2001. Antimicrobial properties of pyridine-2,6-dithiocarboxylic acid, a metal chelator produced by Pseudomonas spp. Appl. Environ. Microbiol. 67:3934-3942.
7. Wade, M. M., and Y. Zhang. 2006. Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro. J. Antimicrob. Chemother. 58:936-941.
8. Zhang, Y. 2005. The magic bullets and tuberculosis drug targets. Annu. Rev. Pharmacol. Toxicol. 45:529-564.